The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries, while strengthening the capabilities of governments and the private sector in those countries to create and sustain high-quality health systems that can succeed without our assistance. For more information, please visit: http://www.clintonhealthaccess.org
CHAI is seeking a Senior Associate to join the Global Vaccines Delivery team to support CHAI's work in improving coverage and equity through new vaccine introductions and enhancing service delivery across focus countries. The Senior Associate will operate at both country-level and global-level to provide strategic and programmatic support.
Projects could include:
This is an opportunity to join a fast paced, energized, matrixed team focused on implementing lasting, transformational impact to the global vaccines delivery space. Candidates should be experienced at analyzing & presenting data and messaging powerfully through written documents and presentations; working collaboratively in a fast-paced, multi-cultural environment; and functioning independently with minimal guidance. This role is perfect for someone with management consulting or analytical experience, who is motivated and mission-oriented with strong quantitative, problem-solving, and cross-cultural communication skills.
Base Location: Preference for this role to be based in a CHAI program country, pending country team leadership approval. Strong preference for sub Saharan Africa (SSA) or a similar time zone.
Key responsibilities of this position include, but are not limited to:
A. At the Country level, provide strategic and programmatic support to the design and implementation of in-country work within a portfolio of focus countries:
B. At the Global level, provide strategic and programmatic support to inform the global community and to develop CHAI’s vaccines program
Overview of CHAI's Vaccines program
Immunization is one of the most successful public health interventions in history. National immunization programs reach >100 million infants every year and have averted globally two to three million deaths every year since the launch of the Expanded Program for Immunization (EPI) in 1974 , whilst the pneumococcal conjugate vaccine (PCV) and rotavirus vaccines could save ~1 million lives per year. Furthermore, great advances in discovering and financing new vaccines provides a great opportunity for countries to further reduce burden of disease such as human papillomavirus (HPV). Despite these successes, 1.5 million children still die each year of vaccine-preventable diseases, many of them in low-income countries, as immunization programs there face unprecedented challenges.
Since 2010, the Clinton Health Access Initiative (CHAI) has worked to save lives and reduce the burden from vaccine preventable diseases by improving access to immunization services in resource-limited setting by strengthening national immunization programs and by leveraging its experience in-country to improve the global immunization ecosystem. CHAI is pursuing six complementary strategic goals:
CHAI's vaccine program very closely supports the national immunization programs in 11 focus countries - Cameroon, Ethiopia, India, Indonesia, Kenya, Lao PDR, Lesotho, Nigeria, Tanzania, Uganda and Vietnam- and also engages with global stakeholders such as Gavi, WHO and UNICEF to inform global policies and practices.
Immunization Service Delivery
Despite significant gains made in immunization coverage from 21% in 1980, global DTP3 coverage has stalled at approximately 85% since 2010, while DTP3 coverage in Africa has stagnated at 76% as of 2015. As a result, nearly one quarter of children under-5 in the region are under- or unimmunized. Immunization coverage is generally much lower for vaccines that are delivered via weaker or complex delivery platforms, such as maternal, neonatal, 9-month, second year and adolescent - whether current vaccines or those slated for introduction. For example, only 28% of African countries have maintained 90% measles conjugate vaccine / measles rubella vaccine first dose (MCV1/MR1) coverage since 2013.
CHAI therefore will develop, test, and scale innovative service delivery interventions in focus countries, with the objective to increase coverage in priority populations in a way that can be scaled and sustained by governments. CHAI will support governments to (i) improve the planning and the performance management of immunization sessions; (ii) improve the linkages of maternal and newborn health services with immunization to increase routine immunization coverage and strengthen the neonatal platform used for OPV, BCG, and HepB birth dose; (iii) increase the routine coverage of the nine-month platform (when vaccines against measles, yellow fever, meningitis A or Typhoid should be administered); and (iv) develop better informed coverage plans and support the implementation of key service delivery strategies to target unimmunized children. CHAI will distill the tools and lessons learned from this work in focus countries and disseminate them to the global community.
 CDC. Global Routine Vaccination Coverage, 2016. https://www.cdc.gov/mmwr/volumes/66/wr/pdfs/mm6645a3-H.PDF
 Since 2011, the uptake of impactful new vaccines, including Pentavalent, PCV and Rotavirus, has significantly progressed, enabled by financial support from Gavi and partners. However, these vaccines relied upon the most effective delivery platform in most countries, one that reaches children between the second to fourth month of life.
 Please see Appendix 4: Acronyms for guidance with acronyms and abbreviations
#jobreference2 #region1 #region2 #region3 #region4